Abstract
Massachusetts General Hospital and Harvard Medical School researchers have devised a way to generate viable oocytes from human germline stem cells. The findings have been licensed by OvaScience, which plans to use the oocyte precursor cells to develop several platforms for restoring fertility in vitro and in vivo.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
